Bausch Health (BHC)
(Delayed Data from NYSE)
$8.62 USD
+0.06 (0.70%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $8.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Income Statements
Fiscal Year end for Bausch Health Cos Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 8,757 | 8,124 | 8,434 | 8,027 | 8,601 |
Cost Of Goods | 2,559 | 2,364 | 2,394 | 2,249 | 2,350 |
Gross Profit | 6,198 | 5,760 | 6,040 | 5,778 | 6,251 |
Selling & Adminstrative & Depr. & Amort Expenses | 5,235 | 5,306 | 5,590 | 5,102 | 6,454 |
Income After Depreciation & Amortization | 963 | 454 | 450 | 676 | -203 |
Non-Operating Income | -25 | 881 | -48 | -76 | -22 |
Interest Expense | 1,328 | 1,464 | 1,426 | 1,534 | 1,612 |
Pretax Income | -390 | -129 | -1,024 | -934 | -1,837 |
Income Taxes | 221 | 83 | -87 | -375 | -54 |
Minority Interest | -19 | 13 | 11 | 1 | 5 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -611 | -212 | -937 | -559 | -1,783 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -592 | -225 | -948 | -560 | -1,788 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,292 | 1,947 | 2,057 | 2,562 | 1,935 |
Depreciation & Amortization (Cash Flow) | 1,329 | 1,493 | 1,607 | 1,886 | 2,138 |
Income After Depreciation & Amortization | 963 | 454 | 450 | 676 | -203 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 365.43 | 362.90 | 359.09 | 354.43 | 351.97 |
Diluted EPS Before Non-Recurring Items | 3.49 | 3.06 | 4.46 | 3.99 | 4.43 |
Diluted Net EPS (GAAP) | -1.62 | -0.62 | -2.64 | -1.58 | -5.08 |
Fiscal Year end for Bausch Health Cos Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2,408.00 | 2,238.00 | 2,167.00 | 1,944.00 |
Cost Of Goods | NA | 705.00 | 623.00 | 649.00 | 582.00 |
Gross Profit | NA | 1,703.00 | 1,615.00 | 1,518.00 | 1,362.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,354.00 | 1,601.00 | 1,106.00 | 1,174.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 349.00 | 14.00 | 412.00 | 188.00 |
Non-Operating Income | NA | -6.00 | -1.00 | -14.00 | -17.00 |
Interest Expense | NA | 363.00 | 339.00 | 319.00 | 307.00 |
Pretax Income | NA | -7.00 | -326.00 | 79.00 | -136.00 |
Income Taxes | NA | 40.00 | 56.00 | 52.00 | 73.00 |
Minority Interest | NA | -8.00 | -4.00 | 1.00 | -8.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -47.00 | -382.00 | 27.00 | -209.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -39.00 | -378.00 | 26.00 | -201.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 354.54 | 366.99 | 371.43 | 365.45 |
Diluted EPS Before Non-Recurring Items | NA | 1.15 | 1.03 | 0.81 | 0.52 |
Diluted Net EPS (GAAP) | NA | -0.11 | -1.03 | 0.07 | -0.55 |